carbon monoxide has been researched along with Angiogenesis, Pathologic in 11 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Excerpt | Relevance | Reference |
---|---|---|
"Carbon monoxide is a gasotransmitter that has been implicated in maintaining vascular tone, increasing angiogenesis, and reducing inflammation and apoptosis at physiological concentrations." | 5.56 | Carbon monoxide increases utero-placental angiogenesis without impacting pregnancy specific adaptations in mice. ( Dickson, MA; McRae, KE; Peterson, N; Pudwell, J; Smith, GN; Tayade, C, 2020) |
"Importantly, in several types of cancer HO-1/CO system exerts opposite activities, making the possible treatment more complicated." | 2.52 | HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy. ( Dulak, J; Jozkowicz, A; Loboda, A, 2015) |
"Carbon monoxide is a gasotransmitter that has been implicated in maintaining vascular tone, increasing angiogenesis, and reducing inflammation and apoptosis at physiological concentrations." | 1.56 | Carbon monoxide increases utero-placental angiogenesis without impacting pregnancy specific adaptations in mice. ( Dickson, MA; McRae, KE; Peterson, N; Pudwell, J; Smith, GN; Tayade, C, 2020) |
" In patients with diabetes, a lower bioavailability of the different gasotransmitters is observed when compared with healthy individuals." | 1.43 | Gasotransmitters in Vascular Complications of Diabetes. ( Greffrath, W; Hammes, HP; Hillebrands, JL; van den Born, JC; van Goor, H, 2016) |
"Carbon monoxide (CO) is a gaseous autacoid known to positively regulate vascular tone; however, its role in angiogenesis is unknown." | 1.42 | Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. ( Ahmad, S; Ahmed, A; Ahmed, SF; Al-Ani, B; Cai, M; Cudmore, M; Fujisawa, T; Gueron, G; Hewett, PW; Otterbein, LE; Ramma, W; Sissaoui, S; VĂtek, L; Wang, K; Wegiel, B; Wong, MK, 2015) |
"Carbon monoxide was a mediator of HMOX1 effects on proliferation, migration, and miR-378 expression." | 1.39 | Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. ( Boczkowski, J; Ciesla, M; Collet, G; Dulak, J; Gil, T; Golda, S; Guichard, A; Jozkowicz, A; Kieda, C; Kozakowska, M; Kuzdzal, J; Loboda, A; Muchova, L; Skrzypek, K; Tertil, M; Vitek, L; Was, H; Weglarczyk, K, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Dickson, MA | 1 |
Peterson, N | 1 |
McRae, KE | 1 |
Pudwell, J | 1 |
Tayade, C | 1 |
Smith, GN | 1 |
Skrzypek, K | 1 |
Tertil, M | 1 |
Golda, S | 1 |
Ciesla, M | 1 |
Weglarczyk, K | 1 |
Collet, G | 1 |
Guichard, A | 1 |
Kozakowska, M | 1 |
Boczkowski, J | 1 |
Was, H | 1 |
Gil, T | 1 |
Kuzdzal, J | 1 |
Muchova, L | 1 |
Vitek, L | 2 |
Loboda, A | 3 |
Jozkowicz, A | 4 |
Kieda, C | 1 |
Dulak, J | 4 |
Ahmad, S | 1 |
Hewett, PW | 1 |
Fujisawa, T | 1 |
Sissaoui, S | 1 |
Cai, M | 1 |
Gueron, G | 1 |
Al-Ani, B | 1 |
Cudmore, M | 1 |
Ahmed, SF | 1 |
Wong, MK | 1 |
Wegiel, B | 1 |
Otterbein, LE | 1 |
Ramma, W | 1 |
Wang, K | 1 |
Ahmed, A | 1 |
van den Born, JC | 1 |
Hammes, HP | 1 |
Greffrath, W | 1 |
van Goor, H | 1 |
Hillebrands, JL | 1 |
Idriss, NK | 1 |
Blann, AD | 1 |
Lip, GY | 1 |
Miller, TW | 1 |
Isenberg, JS | 1 |
Roberts, DD | 1 |
Anderson, H | 1 |
Yap, JT | 1 |
Wells, P | 1 |
Miller, MP | 1 |
Propper, D | 1 |
Price, P | 1 |
Harris, AL | 1 |
Deshane, J | 1 |
Agarwal, A | 1 |
Colle, I | 1 |
Geerts, AM | 1 |
Van Steenkiste, C | 1 |
Van Vlierberghe, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pravastatin to Prevent Preeclampsia and Reduce Maternal-Neonatal Mortality and Morbidity in High Risk Preeclampsia Patients[NCT03648970] | Phase 2 | 280 participants (Anticipated) | Interventional | 2018-03-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for carbon monoxide and Angiogenesis, Pathologic
Article | Year |
---|---|
HO-1/CO system in tumor growth, angiogenesis and metabolism - Targeting HO-1 as an anti-tumor therapy.
Topics: Animals; Antineoplastic Agents; Carbon Monoxide; Heme Oxygenase-1; Humans; Neoplasms; Neovasculariza | 2015 |
Hemoxygenase-1 in cardiovascular disease.
Topics: Animals; Antioxidants; Bilirubin; Carbon Monoxide; Cardiovascular Diseases; Diabetes Mellitus; Heme | 2008 |
Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Carbon Monoxide; Humans; Hydrogen Peroxide; H | 2009 |
Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.
Topics: Angiogenic Proteins; Animals; Carbon Monoxide; Endothelium, Vascular; Heme Oxygenase-1; Humans; Neov | 2008 |
Hemodynamic changes in splanchnic blood vessels in portal hypertension.
Topics: Animals; Biological Factors; Cannabinoid Receptor Modulators; Carbon Monoxide; Collateral Circulatio | 2008 |
1 trial available for carbon monoxide and Angiogenesis, Pathologic
Article | Year |
---|---|
Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane.
Topics: Antineoplastic Agents; Carbon Monoxide; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Neovascular | 2003 |
5 other studies available for carbon monoxide and Angiogenesis, Pathologic
Article | Year |
---|---|
Carbon monoxide increases utero-placental angiogenesis without impacting pregnancy specific adaptations in mice.
Topics: Adaptation, Physiological; Animals; Carbon Monoxide; Carbon Monoxide Poisoning; Cytokines; Embryo Im | 2020 |
Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.
Topics: Animals; Antineoplastic Agents; Carbon Monoxide; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; C | 2013 |
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation.
Topics: Animals; Carbon Monoxide; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Endothelia | 2015 |
Carbon monoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329-337).
Topics: Animals; Carbon Monoxide; Humans; Neovascularization, Pathologic; Vascular Endothelial Growth Factor | 2015 |
Gasotransmitters in Vascular Complications of Diabetes.
Topics: Biological Availability; Carbon Monoxide; Diabetes Mellitus; Diabetic Angiopathies; Gasotransmitters | 2016 |